Tricuspid / Pulmonary valve

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology / World Heart Federation 2023 Scientific Sessions #ACC23 #WCCardio.

Watch the replay of the 1st webinar on Tricuspid valve disease: patient pathways. You’ll learn all about 'Management of tricuspid regurgitation and heart failure'

Watch the replay of the 1st webinar on imaging for transcatheter tricuspid interventions. You’ll learn all about 'Imaging essentials in atrial functional tricuspid regurgitation'

Population-based studies show a higher prevalence of significant TR in women and following that in published and ongoing trials on TTVI more women than men were enrolled. However, so far it has not been investigated whether such differences in epidemiology also would affect TTVI outcomes...

This GulfPCR-GIM 2022 session aims to illustrate the role of mitral TEER in patients with significant MR and cardiogenic shock, to demonstrate the importance of early detection, but also to show that earlier referral and treatment of patients with significant TR is essential to prevent patients...

Thanks to this GulfPCR-GIM 2022 session, get to understand how the TricValve can help in the management of patients with functional TR, know more about the TricValve Bicaval Valves system, and gain insight into the early adoption experience in the Middle East.

Watch the replay of the 2nd webinar on Tricuspid valve disease: patient pathways. You’ll learn all about 'Management of tricuspid valve regurgitation'

Join this discussion which was recorded in the PCR Live studio at PCR London Valves 2022, where Volker Rudolph and Azeem Latib, hosted by Philipp Lurz, talk about some new data and late trials in the field of transcatheter tricuspid valve therapies.

View more videos and course...

Jonathan Curio provides a brief overview of the new data presented at PCR London Valves 2022 in the field of Tricuspid, TAVI and Mitral valves by providing summarised key take-aways!

In this PCR London Valves 2022 session, follow 3 stunning case treatments:

• Part 1: Triscupid TEER (Live)
  A 78-year-old male with a history of CABG (2015), PM-CRT (2015) and atrial fibrillation, presents a severe TR with an LVEF of 40%, preserved RV function and moderate pulmonary hypertension.
  They performed...